| # | Country | Total Patents | |
|---|---|---|---|
| #1 | EPO (European Patent Office) | 4 | |
| #2 | United States | 4 | |
| #3 | Israel | 2 | |
| #4 | WIPO (World Intellectual Property Organization) | 2 | |
| #5 | Canada | 1 | |
| #6 | China | 1 | |
| #7 | Hong Kong | 1 | |
| #8 | India | 1 | |
| #9 | Japan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Medical technology | |
| #2 | Pharmaceuticals | |
| #3 | Chemical engineering | |
| #4 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Syringes | |
| #3 | Medical preparations | |
| #4 | Electrotherapy | |
| #5 | Peptides | |
| #6 | Implantable devices | |
| #7 | Chemical or physical processes | |
| #8 | Separation |
| # | Name | Total Patents |
|---|---|---|
| #1 | Lentz M Rigdon | 8 |
| #2 | Wiesner Peter | 2 |
| #3 | Lentz M R | 2 |
| #4 | Lentz Rigdon M | 2 |
| #5 | Rigdon M Lentz | 1 |
| #6 | Berg Sabine | 1 |
| #7 | Ten Hagen Timo L M | 1 |
| #8 | Heinrich Guenther | 1 |
| #9 | Eggermont Alexander | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2013179143A2 | Sensitization of cancer cells by the removal of soluble tumor necrosis factor receptors | |
| WO2012163544A1 | Removal of soluble tumor necrosis factor receptor 2 (stnfr2) | |
| EP1949915A2 | Method and system to remove soluble TNFR1, TNFR2, and IL2R in patients | |
| EP1079875A2 | Cancer treatment by ultrapheresis removing compounds of less than 120,000 daltons |